Logo-jcvtr

Original Article

1. The Effect of Cyanosis on Active Clotting Time During Diagnostic Catheterization
Akbar Molaei, Majid Malaki*, Shahram Sadegvand
J Cardiovasc Thorac Res. 2012;4(2): 49-52. doi: 10.5681/jcvtr.2012.012
PMCID: PMC3825358     PMID: 24250983    
Article
PDF
XML
Cited By:
0
Original Article

2. Activated clotting time level with weight based heparin dosing during percutaneous coronary intervention and its determinant factors
Majid Soleimannejad, Naser Aslanabadi, Bahram Sohrabi, Morteza Shamshirgaran, Ahmad Separham, Babak Kazemi, Ebrahim Khayati Shal, Reza Madadi, Hamidreza Shirzadi, Hoda Azizi, Samad Ghaffari*
J Cardiovasc Thorac Res. 2014;6(2): 97-100. doi: 10.5681/jcvtr.2014.021
PMCID: PMC4097859     PMID: 25031824    
Article
PDF
XML
Cited By:
2
Original Article

3. Pregnancy outcome in women with mechanical prosthetic heart valvesat their first trimester of pregnancy treated with unfractionated heparin (UFH) or enoxaparin: A randomized clinical trial

Minoo Movahedi, Maryam Motamedi ORCID, Amirreza Sajjadieh* ORCID, Parvin Bahrami ORCID, Mahmood Saeedi, Milad Saeedi
J Cardiovasc Thorac Res. 2020;12(3): 209-213. doi: 10.34172/jcvtr.2020.35
PMCID: PMC7581847     PMID: 33123327     Scopus ID: 85103545474    
Article
PDF
XML
Cited By:
1
1
2
Review Article

4. Coagulopathy: Another side effect of coronavirus infection

Fatemeh Sadoughi, Parisa Maleki Dana, Jamal Hallajzadeh* ORCID, Zatollah Asemi* ORCID, Mohammad Ali Mansournia, Bahman Yousefi
J Cardiovasc Thorac Res. 2021;13(1): 15-22. doi: 10.34172/jcvtr.2020.59
PMCID: PMC8007900     PMID: 33815697     Scopus ID: 85106496777    
Article
PDF
Full Text
XML
Cited By:
0
0
1